Deal Watch: Novo Nordisk Builds On Metabolic Strength Acquiring Partner Embark

 
• By Joseph Haas and Lisa Takagi

Bristol and Regeneron sign separate cell therapy technology pacts, plus deals involving Takeda/ImmunoGen, Serina/AgeX, Cybin/Small Pharma, Taiho/Phost’in, Royalty/Ferring and Aardvark/GRI Bio.

Deal Watch 2021
• Source: Shutterstock

More from Deal Watch

More from Deals